Canaccord Genuity Upgrades Aerie Pharmaceuticals To Buy


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


Canaccord Genuity upgraded Aerie Pharmaceuticals Inc (NASDAQ: AERI) from Hold to Buy.Aerie Pharmaceuticals shares have gained 1.57 percent over the past 52 weeks, while the S&P 500 index has surged 8.07 percent in the same period.Aerie Pharmaceuticals' shares rose 10.73 percent to $22.18 in pre-market trading.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: UpgradesAnalyst RatingsCanaccord Genuity